HIV

Johnson & Johnson and Its Partners Mark a Milestone in the Quest for a Global Preventive HIV Vaccine With the Imbokodo Study

The clinical trial has completed full immunizations of the company's investigational HIV vaccine regimen. Learn what this means for the future of fighting the disease—and also for the creation of a potential vaccine for COVID-19.
Blog

Since the start of the pandemic, Johnson & Johnson has been working to help address the devastating impacts of COVID-19 through the power of its science, the size of its global reach—and the know-how that comes from such experiences as standing up to challenges like HIV.

The Road to a Vaccine, Season 2, Ep. 1: How Lessons Learned in Fighting HIV Help Us Battle COVID-19

Multimedia with summary

In Season 2 of "The Road to a Vaccine," host Lisa Ling interviews scientists, global health leaders and other experts on the COVID-19 front lines to reveal the latest medical advances and collaborations to create a coronavirus vaccine—and hopefully a return to a world without the pandemic.

In the Season 2 premiere, Lisa Ling checks into the AIDS 2020 conference to talk with HIV advocate Laverne Cox and Johnson &. Johnson Chief Scientific Officer Paul Stoffels, M.D., about how HIV vaccine research is informing work on COVID-19 vaccines.

Four Questions with Cleve Jones: Reflecting on the AIDS Memorial Quilt as it Returns Home

Blog

Cleve Jones is a human rights advocate who has long been a champion for people living with HIV and LGBTQ+ equality.

He co-founded the San Francisco AIDS Foundation in 1983. Two years later, he conceived of The AIDS Memorial Quilt at an annual candlelight memorial honoring his mentor Harvey Milk, the politician and civil rights leader who was assassinated in 1978. In 1989, The Quilt was nominated for the Nobel Peace Prize and has become a worldwide symbol of the fight to end the AIDS epidemic.

"AIDS Won't Stop for COVID-19": Meet 3 Inspiring Women Who Are as Committed as Ever to Making HIV History

Summary: 

As the International Aids Society Conference kicks off virtually this year, we sat down with three attendees, including activist and actress Laverne Cox, to talk about their groundbreaking work with HIV/AIDS in the midst of a global pandemic.

Blog

As the International Aids Society Conference kicks off virtually this year, we sat down with three attendees, including activist and actress Laverne Cox, to talk about their groundbreaking work with HIV/AIDS in the midst of a global pandemic.

Our Partners: Tarik Daniels Focuses on Suicide Prevention and Mental Health Through Art, Advocacy and Affirming Care

Blog

Tarik Daniels, founder and Executive Director of the mental health awareness group Whatsinthemirror?, believes art has the power to do more than entertain – it can heal.

After witnessing the traumatic suicide of a neighbor, Tarik suffered from depression for years. His struggles were compounded by an HIV diagnosis, which led to self-doubt and mental health challenges.

Giving Back Never Goes Out of Style: Levi Strauss Foundation Responds to Issues Affecting Marginalized and Disenfranchised Communities

Blog

The Levi Strauss Foundation is the corporate foundation of Levi Strauss & Co., one of the world's largest brand-name apparel companies and a global leader in jeanswear. The Foundation’s philanthropic work is grounded in the company's values of originality, integrity, empathy and courage. Their mission is to advance the human rights and well-being of under-served people around the globe in places where Levi Strauss & Co. has a business presence.

Dine Out (or in) to Give Back – Dining Out for Life® Hosted by Subaru Is Now More Meaningful Than Ever

Article

With the Covid-19 pandemic forcing dramatic changes to our lives and bringing devastating challenges to our restaurants and non-profits, the perennial restaurant fundraiser Dining Out For Life® hosted by Subaru, typically held on the last Thursday in April in cities across North America, will now be delayed in most cities. In Albany, Atlanta, Boulder, Denver, Philadelphia, and San Francisco, it will be held in April as a virtual fundraising event.

Gilead Sciences Statement on Ensuring Continued Supply of HIV Medicine Amid Coronavirus Outbreak

Press Release

FOSTER CITY, Calif., March 25, 2020 /3BL Media/ – For those with potentially immunosuppressing conditions, such as HIV, the uncertainty caused by the novel coronavirus pandemic can be particularly challenging. Gilead remains focused on ensuring that people living with or at risk for HIV have access to the medications and support needed.

Profiles in Creating Possible: Staci Bush Helps Gilead Go Beyond Medicine to Address Barriers to HIV Care Through Partnerships

Blog

Staci Bush can still remember the first time that she, while working as a physician’s assistant at an LGBTQ+ teen health center in Chicago, became aware of the term “single tablet regimen for HIV.”

Several of the teenagers for whom she provided care were already living with HIV and facing a lifetime of complex treatment prior to the innovation of one-pill, once-a-day therapies.

Public- and Private-Sector Partnerships are Key to Ending the HIV Epidemic

Blog

Nearly a year ago, President Trump announced an aspirational goal in his State of the Union address: to reduce the number of new HIV infections in the U.S. by 75% within five years, and by at least 90% within 10 years. This goal is certainly ambitious – but it is not unreachable.

Pages

Subscribe to HIV